Cravacin (Deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
-
2 Articoli
-
1 Foto
-
0 Video
-
Vive a 191/1, Bir Uttam Mir Shawkat SarakTejgaon C/A,Dhaka-1208, Bangladesh
-
Male
-
Seguito da 0 people
Aggiornamenti recenti
-
Cravacin (Deucravacitinib) 6mg: Generic TYK2 Inhibitor for PsoriasisThe landscape of plaque psoriasis treatment has witnessed a revolutionary shift with the introduction of TYK2 inhibitors. For millions of individuals living with moderate-to-severe plaque psoriasis, the daily struggle involves managing itchy, scaly, and often painful skin lesions. While topical creams and traditional systemic treatments have long been the standard, many patients seek a more...0 Commenti 0 condivisioni 75 Views 0 AnteprimaEffettua l'accesso per mettere mi piace, condividere e commentare!
-
0 Commenti 0 condivisioni 67 Views 0 Anteprima
Altre storie